MIT biological engineers found new targets for a better tuberculosis vaccine. They identified specific antigens that may trigger stronger immune responses. These findings could lead to vaccine candidates that protect more effectively. Tuberculosis remains the world’s deadliest infectious disease.
Researchers conducted a large-scale screen of TB proteins to find potential targets. The screening revealed multiple antigens suitable for new vaccine design. From over 4,000 bacterial proteins, scientists pinpointed several highly immunogenic peptides. These peptides caused powerful reactions from T-cells, which fight infections.










